UPDATE : Monday, September 24, 2018
상단여백
Myungmoon Pharm’s valsartan additionally suspended by Lee Hye-seon 2018-08-23 15:10
Ulsan University Hospital professors find acute leukemia therapy candidate by Marian Chu 2018-08-23 15:09
3 multinationals refuse to take pharma group’s anti-corruption system by Nam Doo-hyun 2018-08-23 12:01
Dong-A ST, Takara Bio signs licensing agreement for oncolytic virus therapy by Marian Chu 2018-08-23 11:49
Bridge Biotherapeutics presents preclinical trial results on ATX inhibitor by Marian Chu 2018-08-23 10:31
라인
5 Korean biopharmaceuticals most active in P3 trials in 5 years by Marian Chu 2018-08-23 10:31
Boramae Hospital develops new method that can detect Parkinson’s by Lee Han-soo 2018-08-22 15:03
‘N. Korean defectors’ flu vaccination low due to poor health literacy’ by Choi Gwang-seok 2018-08-22 14:59
Foreign CEOs to lead Korean units of Novartis, Galderma by Nam Doo-hyun 2018-08-22 13:56
Boehringer Ingelheim to present sub-analyses on Pradaxa at ESC Congress 2018 by Marian Chu 2018-08-22 12:31
라인
Merck to globally distribute T&R Biofab’s bio-ink by Lee Han-soo 2018-08-22 12:30
Lixiana faces patent challenge in substance, composition by Lee Hye-seon 2018-08-22 11:16
Shire Korea gets approval for short bowel syndrome treatment by Marian Chu 2018-08-22 11:15
Politician sponsors bill to honor medical professionals by Marian Chu 2018-08-21 18:12
Pharma group will no longer provide souvenirs to medical workers by Lee Han-soo 2018-08-21 18:11
라인
Handok releases special medical food for Alzheimer’s by Lee Han-soo 2018-08-21 15:57
Daiichi Sankyo publishes 1st RWD on Lixiana on Koreans by Marian Chu 2018-08-21 15:57
[Special] Pharmaceuticals at odds with government over selective benefit system by Nam Doo-hyun 2018-08-21 15:57
Sanofi Pasteur, KSOC vaccinate S. Korean national squad for 2018 Asian Games by Marian Chu 2018-08-21 11:50
SNUBH, Macrogen to cooperate on precision medicine by Lee Han-soo 2018-08-21 11:50
여백
여백
여백
Back to Top